Skip to main content

Table 4 Analysis of maternal and neonatal outcomes after PSM

From: Maternal and perinatal risks for monozygotic twins conceived following frozen-thawed embryo transfer: a retrospective cohort study

Outcomes

DZT (N = 246)

MZT (N = 124)

OR (95% CI)

Maternal outcomes

   

Hypertensive disorders in pregnancy

17 (6.91%)

7 (5.65%)

0.81 (0.30–1.92)

Gestational diabetes

18 (7.32%)

7 (5.65%)

0.76 (0.29–1.79)

Intrahepatic cholestasis of pregnancy

2 (0.81%)

2 (1.61%)

2.00 (0.24–16.8)

Placenta previa

3 (1.22%)

2 (1.61%)

1.33 (0.17–8.11)

Placental abruption

0 (0.00%)

0 (0.00%)

NA

Preterm premature rupture of the membranes

27 (11.0%)

31 (25.0%)

2.70 (1.53–4.81)

Cesarean delivery

241 (98.0%)

120 (96.8%)

0.62 (0.16–2.55)

Neonatal outcomes

   

Neonatal death

1 (0.41%)

4 (3.25%)

8.24 (1.20–162)

Preterm birth, < 37 weeks

106 (43.3%)

86 (72.3%)

3.42 (2.14–5.55)

Very preterm birth, < 32 weeks

7 (2.86%)

4 (3.36%)

1.18 (0.30-4.00)

Extremely preterm birth, < 28 weeks

1 (0.41%)

1 (0.84%)

2.07 (0.08–52.6)

Low birth weight, < 2500 g

126 (51.4%)

84 (70.6%)

2.27 (1.43–3.65)

Very low birth weight, < 1500 g

9 (3.67%)

5 (4.20%)

1.15 (0.35–3.41)

Small for gestational age

13 (5.31%)

16 (13.4%)

2.77 (1.29–6.07)

Large for gestational age

64 (26.1%)

13 (10.9%)

0.35 (0.18–0.64)

Macrosomia, > 4000 g

1 (0.41%)

0 (0.00%)

NA

Birth weight discordance

44 (18.0%)

10 (8.4%)

0.42 (0.19–0.83)

Stillbirth

0 (0.00%)

1 (0.81%)

NA

Birth defects

7 (2.85%)

5 (4.07%)

1.45 (0.42–4.63)

Neonatal jaundice

3 (1.22%)

4 (3.36%)

NA

Pneumonia

0 (0.00%)

2 (1.68%)

NA

Respiratory distress syndrome

0 (0.00%)

0 (0.00%)

NA

Intestinal necrosis

0 (0.00%)

0 (0.00%)

NA

  1. CI, confidence interval; DZT, dizygotic twins; MZT, monozygotic twins; NA, not applicable; OR, odds ratio